Jones Financial Companies
ATNM icon

Jones Financial Companies’s Actinium Pharmaceuticals ATNM Stock Holding History

Jones Financial Companies’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34K Buy
1,351
+1,000
+285% +$1.16K ﹤0.01% 4538
2026
Q1 		$362 Hold
351
– – ﹤0.01% 4543
2025
Q4 		$477 Hold
351
– – ﹤0.01% 4170
2025
Q3 		$565 Buy
351
+51
+17% +$83 ﹤0.01% 4021
2025
Q2 		$426 Buy
+300
New +$449 ﹤0.01% 3825

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jones Financial Companies's ATNM Position: Q2 2026 in Review

Jones Financial Companies increased its Actinium Pharmaceuticals (ATNM) stake by 285% in Q2 2026, buying an estimated $1.16K and bringing the position to 1,351 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4538.

Jones Financial Companies first reported a position in ATNM in Q2 2025 and has held it in 5 quarters since. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Jones Financial Companies held 1,351 shares of Actinium Pharmaceuticals worth $1.34K as of Q2 2026.
  • Jones Financial Companies bought 1,000 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.16K.
  • Actinium Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4538 holding.
  • Jones Financial Companies first reported a position in Actinium Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.